BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Huong D Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, Lesley McGuffog, Steve Ellis, Bingjian Feng, Saundra S Buys, John L Hopper, Melissa C Southey, Andrea Tesoriero, Paul A James, Fiona Bruinsma, Ian G Campbell, Annegien Broeks, Marjanka K SchmidtFrans B L Hogervorst, Matthias W Beckman, Peter A Fasching, Olivia Fletcher, Nichola Johnson, Elinor J Sawyer, Elio Riboli, Susana Banerjee, Usha Menon, Ian Tomlinson, Barbara Burwinkel, Ute Hamann, Frederik Marme, Anja Rudolph, Ramunas Janavicius, Laima Tihomirova, Nadine Tung, Judy Garber, Daniel Cramer, Kathryn L Terry, Elizabeth M Poole, Shelley S Tworoger, Cecilia M Dorfling, Elizabeth J van Rensburg, Andrew K Godwin, Stig E Bojesen, Anne-Marie Gerdes, Susanne K Kjaer, Claus Hogdall, Estrid Hogdall, EMBRACE
Dyk ned i forskningsemnerne om 'BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers'. Sammen danner de et unikt fingeraftryk.